Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study
AUTOR(ES)
Hyett, Jon
FONTE
British Medical Journal
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27679Documentos Relacionados
- Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation.
- Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks' gestation: prospective community based cohort study
- Nuchal translucency: an ultrasound marker for fetal chromosomal abnormalities
- 3rd International Symposium on the Immunotherapy of the Rheumatic Diseases. 10-14 May 1995, Cyprus. Abstracts.
- Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study